Atomwise BenevolentAI

Related Products

  • JDisc Discovery
    4.8 out of 5 stars 30 Ratings
    Visit Website for JDisc Discovery
  • AthenaHQ
    4.9 out of 5 stars 41 Ratings
    Visit Website for AthenaHQ
  • Criminal IP ASM
    4.9 out of 5 stars 21 Ratings
    Visit Website for Criminal IP ASM
  • Superfiliate
    5.0 out of 5 stars 50 Ratings
    Visit Website for Superfiliate
  • Digital WarRoom
    4.6 out of 5 stars 55 Ratings
    Visit Website for Digital WarRoom
  • FrameworkLTC
    4.4 out of 5 stars 48 Ratings
    Visit Website for FrameworkLTC
  • Cloverleaf
    4.8 out of 5 stars 189 Ratings
    Visit Website for Cloverleaf
  • Eurekos
    4.8 out of 5 stars 103 Ratings
    Visit Website for Eurekos
  • 11x
    4.3 out of 5 stars 69 Ratings
    Visit Website for 11x
  • Safetica
    4.7 out of 5 stars 416 Ratings
    Visit Website for Safetica
Atomwise:

About

We use our AI engine to transform drug discovery. Our discoveries help create better medicines faster. Our AI-enabled discovery portfolio includes wholly-owned and co-developed pipeline assets, and is backed by prominent investors. Atomwise developed a machine-learning-based discovery engine that combines the power of convolutional neural networks with massive chemical libraries to discover new small-molecule medicines. The secret to reinventing drug discovery with AI is people. We are dedicated to developing the best AI platform and using it to transform small molecule drug discovery. We have to tackle the most challenging, seemingly impossible targets and streamline the drug discovery process to give drug developers more shots on goal. Computational efficiency enables screening of trillions of compounds in silico, increasing the likelihood of success. Demonstrated exquisite model accuracy, overcoming the challenge of false positives.
BenevolentAI:

About

BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates.
Atomwise:

Platforms Supported

Windows Not Supported
Mac Not Supported
Linux Not Supported
Cloud Supported
On-Premises Not Supported
iPhone Not Supported
iPad Not Supported
Android Not Supported
Chromebook Not Supported
BenevolentAI:

Platforms Supported

Windows Not Supported
Mac Not Supported
Linux Not Supported
Cloud Supported
On-Premises Not Supported
iPhone Not Supported
iPad Not Supported
Android Not Supported
Chromebook Not Supported
Atomwise:

Audience

Researchers and labs searching for an artificial intelligence solution designed for drug discovery
BenevolentAI:

Audience

Researchers, biopharma teams, and drug discovery professionals requiring a solution to uncover biological insights, identify therapeutic targets, and accelerate the development of new medicines
Atomwise:

Support

Phone Support Not Supported
24/7 Live Support Not Supported
Online Supported
BenevolentAI:

Support

Phone Support Supported
24/7 Live Support Not Supported
Online Supported
Atomwise:

API

Offers API Not Supported
BenevolentAI:

API

Offers API Not Supported
Atomwise:

Screenshots and Videos

BenevolentAI:

Screenshots and Videos

Atomwise:

Pricing

No information available.
Free Version Not Supported
Free Trial Not Supported
BenevolentAI:

Pricing

No information available.
Free Version Not Supported
Free Trial Not Supported
Atomwise:

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software
BenevolentAI:

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software
Atomwise:

Training

Documentation Supported
Webinars Supported
Live Online Not Supported
In Person Supported
BenevolentAI:

Training

Documentation Supported
Webinars Not Supported
Live Online Supported
In Person Not Supported
Atomwise:

Company Information

Atomwise
Founded: 2012
United States
www.atomwise.com
BenevolentAI:

Company Information

BenevolentAI
Founded: 2013
Luxembourg
www.benevolent.com
Atomwise:

Alternatives

StarDrop

StarDrop

Optibrium
BenevolentAI:

Alternatives

Atomwise:
BenevolentAI:
Atomwise:
AIDDISON

AIDDISON

Merck KGaA
BenevolentAI:
Atomwise:
BenevolentAI:
Scitara DLX

Scitara DLX

Scitara
Atomwise:
BenevolentAI:
Atomwise:

Categories

Drug Discovery Supported
Healthcare AI Supported
BenevolentAI:

Categories

AI Science Supported
Drug Discovery Supported
Life Sciences Supported
Atomwise:

Integrations

No info available.
BenevolentAI:

Integrations

No info available.
Atomwise:
Claim Atomwise and update features and information
Claim Atomwise and update features and information
BenevolentAI:
Claim BenevolentAI and update features and information
Claim BenevolentAI and update features and information